133 related articles for article (PubMed ID: 25248518)
1. p63 and E-cadherin Expression in Canine Oral Squamous Cell Carcinoma.
Mestrinho LA; Pissarra H; Faísca PB; Bragança M; Peleteiro MC; Niza MM
Vet Pathol; 2015 Jul; 52(4):614-20. PubMed ID: 25248518
[TBL] [Abstract][Full Text] [Related]
2. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior.
Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L
Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970
[TBL] [Abstract][Full Text] [Related]
4. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin and vimentin in oral squamous cell carcinoma.
Zhou J; Tao D; Xu Q; Gao Z; Tang D
Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
7. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
9. PCNA and grade in 13 canine oral squamous cell carcinomas: association with prognosis.
Mestrinho LA; Faísca P; Peleteiro MC; Niza MM
Vet Comp Oncol; 2017 Mar; 15(1):18-24. PubMed ID: 25524719
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin and involucrin in leukoplakia and oral cancer: an immunocytochemical and immunohistochemical study.
Silva AD; Maraschin BJ; Laureano NK; Daroit N; Brochier F; Bündrich L; Visioli F; Rados PV
Braz Oral Res; 2017 Mar; 31():e19. PubMed ID: 28273205
[TBL] [Abstract][Full Text] [Related]
11. Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
Pereira CH; Morais MO; Martins AF; Soares MQ; Alencar Rde C; Batista AC; Leles CR; Mendonça EF
Arch Oral Biol; 2016 Jan; 61():8-15. PubMed ID: 26476747
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: an immunohistochemical study.
Kaur G; Carnelio S; Rao N; Rao L
Indian J Dent Res; 2009; 20(1):71-6. PubMed ID: 19336864
[TBL] [Abstract][Full Text] [Related]
14. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116
[TBL] [Abstract][Full Text] [Related]
15. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
18. Pattern of p63 expression in squamous cell carcinoma of the oral cavity.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Gatto MR; Frezza GP; Pession A
Virchows Arch; 2004 Apr; 444(4):332-9. PubMed ID: 14997391
[TBL] [Abstract][Full Text] [Related]
19. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
